## **Core Concept**
The question revolves around the management of diabetes in preconceptional women, focusing on the optimal value of glycosylated hemoglobin (HbA1c). HbA1c is a critical marker for assessing long-term glycemic control in diabetic patients. Preconceptional care in diabetic women is essential to minimize risks of congenital anomalies and pregnancy-related complications.

## **Why the Correct Answer is Right**
The correct answer, 7% - This value is considered too high for preconceptional diabetic women. Values above 7% increase the risk of congenital anomalies and are associated with poorer outcomes.
- **Option B:** <7% - While <7% is a general target for many diabetic patients, the more stringent target of <6.5% is specifically recommended for preconceptional women to minimize risks. - **Option D:** <8% - This option is also too high for a preconceptional target. An HbA1c <8% does not provide the same level of protection against congenital anomalies as <6.5%. ## **Clinical Pearl / High-Yield Fact** A key clinical pearl is that diabetic women should achieve optimal glycemic control before becoming pregnant. The American College of Obstetricians and Gynecologists (ACOG) and the American Diabetes Association (ADA) recommend an HbA1c target of <6.5% for women with diabetes who are planning pregnancy. This helps in reducing the risk of congenital malformations and ensuring a healthier pregnancy outcome. ## **Correct Answer:** . <6.5%